We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$191M
AUM Growth
-$2.44M
Cap. Flow
+$841K
Cap. Flow %
0.44%
Top 10 Hldgs %
22.19%
Holding
197
New
26
Increased
47
Reduced
53
Closed
23

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$1.07M
2
ILMN icon
Illumina
ILMN
+$1.04M
3
IRM icon
Iron Mountain
IRM
+$1.04M
4
AVT icon
Avnet
AVT
+$1.02M
5
LII icon
Lennox International
LII
+$972K

Top Sells

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$1.84M
2
PPG icon
PPG Industries
PPG
+$1.78M
3
KNX icon
Knight Transportation
KNX
+$1.3M
4
WAB icon
Wabtec
WAB
+$1.12M
5
CVS icon
CVS Health
CVS
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 20.35%
2 Healthcare 16.92%
3 Technology 16.65%
4 Consumer Staples 12.74%
5 Financials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
51
FedEx
FDX
$73B
$1.24M 0.65%
5,650
+2,125
+60% +$577K
QRVO icon
52
Qorvo
QRVO
$10.4B
$1.22M 0.64%
7,285
+2,655
+57% +$493K
CARR icon
53
Carrier Global
CARR
$45.8B
$1.22M 0.64%
23,475
-50
-0.2% -$2.69K
ELV icon
54
Elevance Health
ELV
$90.6B
$1.21M 0.63%
3,240
AZN icon
55
AstraZeneca
AZN
$251B
$1.2M 0.63%
9,963
+1,888
+23% +$220K
XOM icon
56
ExxonMobil
XOM
$696B
$1.17M 0.61%
19,868
-302
-1% -$17.2K
UNP icon
57
Union Pacific
UNP
$169B
$1.15M 0.6%
5,841
GIS icon
58
General Mills
GIS
$19.6B
$1.14M 0.6%
19,088
+250
+1% +$14.8K
INDB icon
59
Independent Bank
INDB
$3.96B
$1.12M 0.58%
14,658
CI icon
60
Cigna
CI
$76.3B
$1.11M 0.58%
5,550
+3,075
+124% +$669K
SBUX icon
61
Starbucks
SBUX
$110B
$1.1M 0.58%
9,990
+1,235
+14% +$145K
PEP icon
62
PepsiCo
PEP
$185B
$1.07M 0.56%
7,110
SYF icon
63
Synchrony
SYF
$24.7B
$1.06M 0.56%
21,795
-475
-2% -$23.1K
CME icon
64
CME Group
CME
$98.9B
$1.02M 0.54%
+5,300
New +$1.07M
MDT icon
65
Medtronic
MDT
$120B
$1.02M 0.53%
8,119
UTHR icon
66
United Therapeutics
UTHR
$21.5B
$1.01M 0.53%
5,450
+4,325
+384% +$852K
IRM icon
67
Iron Mountain
IRM
$33.4B
$1M 0.53%
+23,100
New +$1.04M
MRNA icon
68
Moderna
MRNA
$57.4B
$982K 0.51%
2,551
-149
-6% -$55K
AVT icon
69
Avnet
AVT
$7.6B
$958K 0.5%
+25,905
New +$1.02M
AMD icon
70
Advanced Micro Devices
AMD
$823B
$951K 0.5%
9,245
+3,970
+75% +$406K
INTC icon
71
Intel
INTC
$513B
$944K 0.49%
17,726
-300
-2% -$16.3K
CMI icon
72
Cummins
CMI
$74.1B
$943K 0.49%
4,200
+1,450
+53% +$340K
NEE icon
73
NextEra Energy
NEE
$169B
$932K 0.49%
11,865
-300
-2% -$24.2K
ILMN icon
74
Illumina
ILMN
$33.6B
$892K 0.47%
+2,262
New +$1.04M
CAG icon
75
Conagra Brands
CAG
$7.21B
$886K 0.46%
26,150
+10,925
+72% +$370K

Similar funds

New England Research & Management's Q3 2021 Portfolio in Review

As of Q3 2021, New England Research & Management held 197 positions worth $191M, down 1.3% from $193M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2021 filing shows 26 new, 47 increased, 53 reduced and 23 closed positions. Its largest new stake was CME Group: 5,300 shares worth $1.02M. The largest sale was Air Products & Chemicals, an estimated $1.84M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q3 2021 buy was CME Group: 5,300 shares worth $1.02M.
  • New England Research & Management added most to Lennox International in Q3 2021, an estimated $972K increase.
  • New England Research & Management's biggest Q3 2021 reduction was Knight Transportation, cutting an estimated $1.3M.
  • New England Research & Management fully exited Air Products & Chemicals in Q3 2021, selling an estimated $1.84M.
  • New England Research & Management's ten largest holdings make up 22% of its $191M portfolio in Q3 2021.
  • New England Research & Management opened 26 new positions and closed 23 in Q3 2021.
  • New England Research & Management's portfolio value fell 1.3% quarter-over-quarter to $191M.

Based on New England Research & Management's 13F filing for Q3 2021, filed 8 Oct 2021.